NewLink Genetics Corp NLNK 9.79% and licensing partner Merck & Co., Inc. MRK 0.03% appear to have made a major breakthrough in prevention of one of the deadliest diseases in the world. This week, The Lancet reported 100 percent efficacy in Merck’s final-stage trial of an experimental Ebola vaccine administered to more than 11,000 people exposed to the disease during a 2013–2016 outbreak in Guinea.
The outbreak killed more than 11,300 people in West Africa.
“While these compelling results come too late for those who lost their lives during West Africa’s Ebola epidemic, they show that when the next Ebola outbreak hits, we will not be defenseless,” the World Health Organization’s Marie-Paule Kieny said.
Shares of the $162 billion pharma giant Merck barely moved on the news, but shares of $313 million NewLink were up 10.49 percent in Friday’s session.
Competitors In The Space Rejoice Alongside Merck, NewLink
Surprisingly, shares of rival Ebola vaccine biotech stocks are joining in on the NewLink rally, even though their vaccine research is in much earlier stages. Sarepta Therapeutics Inc SRPT 6.18% shares were up 4.97 percent on Friday. The company’s Ebola vaccine candidate is currently in Phase I testing.
BioCryst Pharmaceuticals, Inc. BCRX 9.22% shares were up by 7.9 percent. The company’s Ebola vaccine candidate is…
Click here to continue reading
Want to learn more about how to profit off the stock market? Or maybe you just want to be able to look sophisticated in front of your coworkers when they ask you what you are reading on your Kindle, and you’d prefer to tell them “Oh, I’m just reading a book about stock market analysis,” rather than the usual “Oh, I’m just looking at pics of my ex-girlfriend on Facebook.” For these reasons and more, check out my book, Beating Wall Street with Common Sense. I don’t have a degree in finance; I have a degree in neuroscience. You don’t have to predict what stocks will do if you can predict what traders will do and be one step ahead of them. I made a 400% return in the stock market over five years using only basic principles of psychology and common sense. Beating Wall Street with Common Sense is now available on Amazon, and tradingcommonsense.com is always available on your local internet!
